GLP-1 receptor agonists + SGLT2 inhibitors

Papers on GLP-1 receptor agonists + SGLT2 inhibitors

37 papers10 new in 30 days

Monday, November 3

AHA Scientific Sessions 2025 AbstractNov 3

Effect of Combination Therapy With GLP-1 Receptor Agonists and SGLT2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes and ASCVD: A Systematic Review and Meta-analysis

Study of 166,325 peopleGLP-1 receptor agonists

Friday, June 13

ADA Scientific Sessions 2025 AbstractJun 13

Real-World Efficacy of Combined SGLT2i and GLP-1RA Therapy in Elderly Patients with Type 2 Diabetes and Obesity

Cohort study of 94 peopleSGLT2 inhibitors

ADA Scientific Sessions 2025 AbstractJun 13

Retrospective Effects of GLP-1 Receptor Agonists with and without Concomitant SGLT2 Inhibitor Use in Diabetic Renal Transplant Recipients after 12 Months

Cohort study of 18 peopleSGLT2 inhibitors

Monday, March 17

Scientific ReportsMar 17

Longitudinal association of SGLT2 inhibitors and GLP-1RAs on falls in persons with type 2 diabetes

Cohort study of 471 peopleType 2 diabetes

Wednesday, February 26

Journal of the American Heart AssociationFeb 26

Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes

Cohort study of 163 peopleSGLT2 inhibitors

Monday, December 16

American Journal of Translational ResearchDec 16

Efficacy and safety of GLP-1 receptor agonists combined with SGLT-2 inhibitors in elderly patients with type 2 diabetes: a meta-analysis

Meta-analysis of randomized trialsSGLT2 inhibitors

Tuesday, November 13

Canadian Journal of DiabetesNov 13

Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study

Cohort study of 113 peopleSGLT2 inhibitors